Clinical Trials

topic on 11 shows · 31 statements across 25 episodes

the Y Combinator Startup Podcast Cheeky Pint We Live to Build Masters of Scale No Priors Capital Allocators Top Founders the MAD Podcast the a16z Podcast All-In 20VC

31 statements about Clinical Trials, every show

ALL-IN Assertion Not checkable as stated
Chamath: AI is bringing previously discarded drug candidates into clinical trials
“There are drug candidates that are about to enter clinical trials and INDs that were sitting on the shelf and people didn't think were very viable at all.”
Chamath Palihapitiya May 22, 2026 ▶ 10:34 SpaceX’s $2T Case, Nvidia’s Shock Selloff, America Turns on AI, Trump Pulls AI Order, Bond Crisis?
a16z Assertion Contradicted
Sankar: China now hosts 50% of all global clinical trials
“We used to think Wuxi was just some cheap set of pipetting arms for contract pharmaceutical research, and now, 50% of all clinical trials are being done in China.”
Shyam Sankar Mar 20, 2026 ▶ 31:51 Palantir CTO on The SaaS Apocalypse & Preventing The Next World War | a16z
NO PRIORS Insight
Wickramasekara: Clinical trial optimization is a red herring versus molecule quality
“People get very focused on clinical trials because they're like the biggest line item. And they're important, don't get me wrong, but I think it's actually a bit of a red, red herring. Where, ah, yes, there are operational problems. Like, some studies are desi…”
Sajith Wickramasekara Nov 13, 2025 ▶ 13:12 No Priors Ep. 140 | With Benchling Co-Founder and CEO Sajith Wickramasekara
CHEEKY PINT Prediction Partly held up
Ricks: Machine-designed drugs haven't reached clinical trials yet, but are coming
“I don't know of one that's come through the machine driven discovery process, which is really machine plus human that's made it to the clinic yet, but they're coming.”
Dave Ricks Nov 11, 2025 ▶ 3:19 Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma
a16z Assertion Not checkable as stated
Conde: AI has not yet compressed biotech clinical trial timelines
“We still haven't seen, and I think it's coming, but it hasn't happened yet. We haven't seen artificial intelligence or other technologies massively compress the amount of time it takes us to do the clinical development, the clinical trials, the enrollment of p…”
Jorge Conde Sep 15, 2025 ▶ 28:45 Faster Science, Better Drugs
ALL-IN Prediction Not checkable as stated
Buchheit: AI will outperform clinical drug trials within 20 years
“In 20 years, we'll be able to know how a drug affects the body without ever actually testing it. And my prediction is actually Our AI models will be more predictive than today's clinical trials.”
Paul Buchheit Jul 23, 2025 ▶ 1:06:19 Winning the AI Race Part 1: Michael Kratsios, Kelly Loeffler, Shyam Sankar, Chris Power
ALL-IN Assertion Supported
Palihapitiya: China now matches the U.S. in active clinical trial volume
“And there are as many clinical trials now in China as there are in the United States, and oftentimes they're bigger, which is to say that the amount of innovation and the surface area there is already exceeding what's happening in the West.”
Chamath Palihapitiya May 17, 2025 ▶ 1:27:32 Trump's Big Week: Middle East Trip, China Deal, Pharma EO, "Big, Beautiful Bill" with Ben Shapiro
NO PRIORS Insight
Afeyan: Molecular microstaging can prevent clinical trial failures using AI
“I think we now have the tools to be able to, in a very Kind of molecular way, microstage, what I call our biostage disease on a trajectory that isn't four stages, but it's 75,000 stages if you want. And the key for that is that you can then look at what mechan…”
Noubar Afeyan Feb 27, 2025 ▶ 30:28 No Priors Ep. 104 | With Flagship Pioneering CEO and Co-Founder Noubar Afeyan
MASTERS OF SCALE Assertion Supported
Women were historically excluded from clinical trials until roughly 20 years ago
“Women, you know, women have been historically underserved by medicine because people weren't studying women's physiology with, you know, in clinical trials up until the last 20 years or so.”
Tom Hale Jan 9, 2025 ▶ 29:46 How Ōura doubled ring sales in two years (with CEO Tom Hale) | Masters of Scale
a16z Assertion Supported
Ganguli: 80% of clinical trials fail to meet enrollment targets
“Like, 80% of clinical trials just fail to meet enrollment targets, right?”
Surya Ganguli Oct 3, 2024 ▶ 22:51 AI at the Intersection of Bio | Vijay Pande, Surya Ganguli & Bowen Liu
a16z Insight
Pande: Small AI efficiency gains in high-cash-flow clinical trials yield massive impact
“Like, I'm working on, like, something, you know, in drug design or whatever to make big leaps and bounds, and small things for big cash flows can have a huge impact. So something for clinical trials could be huge, or even just picking, like, the order of rank …”
Vijay Pande Jun 28, 2024 ▶ 35:08 Grand Challenges in Healthcare AI with Vijay Pande and Julie Yoo
Kuruvilla: A 10% edge in biotech trial forecasting creates outsized alpha
“It's the same thing in our field here, where if you can be even 10% better than the average, then you're going to be an all star because these events tend to be so Dramatic. So companies can go up two or three fold, a hundred percent, 200% moves overnight, or …”
Finny Kuruvilla Oct 12, 2023 ▶ 27:43 Finny Kuruvilla – The Fourth Source of Alpha at Eventide (EP.343)
ALL-IN Prediction Didn’t hold up
Siren Biotechnology plans human trials for brain cancer gene therapy in 2025
“And we're queuing up for a clinical trial in twenty-twenty-five. So we're excited to start our clinical trial in twenty-twenty-five”
Dr. Nicole Paulk Sep 25, 2023 ▶ 16:22 All-In Summit: Gene therapy and a new era of medicine with Dr. Nicole Paulk
ALL-IN Assertion Contradicted
FDA blocks clinical trials for lifestyle gene therapies like aging or sleep
“The FDA only lets you queue up clinical trials to test drugs that are for diseases, but aging is not a disease state. Wanting to sleep fewer hours is not a disease state. Insomnia is, but wanting to just sleep fewer hours and be fully rested is not a disease s…”
Dr. Nicole Paulk Sep 25, 2023 ▶ 20:23 All-In Summit: Gene therapy and a new era of medicine with Dr. Nicole Paulk
NO PRIORS Assertion Supported
Biewald: No ML-Developed Drug Has Ever Completed Clinical Trials
“So no drug developed by ML has gone through clinical trials.”
Lukas Biewald Aug 3, 2023 ▶ 26:53 No Priors Ep. 26 | With Weights & Biases CEO Lukas Biewald
NO PRIORS Insight
Koller: Drug discovery lacks clinical outcome ML training data until trials
“Because when you think about it, it's the one area where you really don't have the right type of training data, at least not obviously, because the question you're asking yourself is, if I make this therapeutic intervention in this patient, what is it going to…”
Daphne Koller May 19, 2023 ▶ 14:03 No Priors Ep. 6 | With Daphne Koller from Insitro
NO PRIORS Insight
Koller: Broad patient targeting to maximize revenue causes drug trial failures
“That is one of the big things that causes drugs to fail is that you are trying to apply it more broadly. If I'm being cynical, sometimes it's supposed to maximize the revenues that you can get from a drug versus trying to figure out exactly in which patients i…”
Daphne Koller May 19, 2023 ▶ 28:23 No Priors Ep. 6 | With Daphne Koller from Insitro
WE LIVE TO BUILD Assertion Supported
Current antidepressant use is an exclusion criterion in psychedelic clinical trials
“Being on an antidepressant so far is an exclusionary criteria in probably all the clinical trials right now.”
Dr. Linda Strauss Apr 28, 2022 ▶ 22:45 Psilocybin Breaks Neural Connections - Then Therapy Rewires Them
TOP FOUNDERS Assertion Not publicly verifiable
Clair Labs detects 95% of COPD hospitalizations seven to eight days early
“What we are showing is Is that we are raising the, an accurate alarm flag seven to eight days before very, I mean, in very high rates, like 95%, ok? 95% of the hospitalization cases of the clinical trials of the sample we sampled. We are showing a very obvious…”
Adi Berenson Dec 28, 2021 ▶ 9:39 HealthTech Device Prevents COPD Patients from Hospital Visits, $9m Raised, 50 Devices Shipped
20VC Assertion Not checkable as stated
Kaul: Shortening clinical trials saves $1M per day to healthcare
“Every day you shorten clinical trials is a million dollars that is saved to the healthcare system.”
Samir Kaul Jan 13, 2020 ▶ 33:54 20VC: Khosla Ventures Founding Partner, Samir Kaul on Why Pro Rata Is A Cop Out, Why He Likes Technical Risk and Does Not Take Market Risk & How To Approach Time Allocation Across The Portfolio In Venture
TOP FOUNDERS Disclosure
Givoly: Medivisor's clinical trial acceleration deals are six-figure contracts
“It's usually bigger, longer deals to longer term engagement. So, for example, a clinical trial that wants to be accelerated, it could be a six-figure deal to work with us to help accelerate that trial.”
Tal Givoly Aug 12, 2019 ▶ 11:26 1479 Are they actually better than WebMD w $500k+ in Revenue?
TOP FOUNDERS Assertion Not checkable as stated
Walpole: Trials.ai cuts study design time from 9–12 months to weeks
“On the study design side, you know, it takes anywhere from nine to 12 months to do that. We're cutting that down to weeks and eventually days.”
Kim Walpole Mar 1, 2019 ▶ 4:01 1315 Her Best Friend Died From Terminal Cancer, She Launches MedTech SaaS Raising $2.5m on $10m Pre
a16z Prediction Not checkable as stated
Pande: Real-world evidence will surpass clinical trials in utility
“And what I think we'll start to see is, especially as new statistical methods come online, that real world evidence will be very useful, in some ways will be more useful than what you can do in a clinical trial, both due to power and due to the fact of real li…”
Vijay Pande Jan 17, 2019 ▶ 19:08 a16z Podcast | Dark Data in Healthcare
a16z Assertion Partly supported
Sethi: Over 90% of clinical trials fail to recruit enough patients
“Most clinical trials, upwards of 90% or worse, don't get filled, and it's because there's no frictionless way for a clinical trial's inclusion-exclusion criteria to detect a candidate patient.”
Anil Sethi Jan 17, 2019 ▶ 27:17 a16z Podcast | Dark Data in Healthcare
a16z Prediction Not checkable as stated
Fox: Patients with data access will form coalitions to demand clinical trials
“When patients all have access to their data, They could form a coalition and ask for a certain clinical trial.”
Susanna Fox Jan 17, 2019 ▶ 28:20 a16z Podcast | Dark Data in Healthcare
a16z Assertion Not checkable as stated
Narasimhan: Scaling technology in clinical trials could cut costs by 20%
“There are estimates now from various sources that believe you could take out 20% of clinical trials costs if you were to actually to really deploy technology at scale.”
Vas Narasimhan Jan 17, 2019 ▶ 7:15 a16z Podcast | The Science and Business of Innovative Medicines
a16z Disclosure
Novartis built AI command center Sense to track global clinical trials
“So we've built an operational command center. Take us, as I said, two and a half years to build it. We call it sense. And what it enables us to do a team sitting centrally in our headquarters to look at all of our clinical trials in the world. And AI is predic…”
Vas Narasimhan Jan 17, 2019 ▶ 38:12 a16z Podcast | The Science and Business of Innovative Medicines
a16z Assertion Not checkable as stated
Wearable sensors have failed to meet clinical trial validation standards
“When I think about, first of all, I would say just in general in sensors is another place where there's been a lot of hype Above what, of expectations. I mean, we've been really trying to explore the use of sensors in clinical trials now for, in my own experie…”
Vas Narasimhan Jan 17, 2019 ▶ 43:10 a16z Podcast | The Science and Business of Innovative Medicines
Iorns: Human longevity trials are impractical without secondary biomarker endpoints
“If you do that invention, you do that intervention in humans, you're going to have to wait A really long time to know whether it actually worked, and so that clinical study is very difficult if you don't have a secondary endpoint that you can measure.”
Elizabeth Iorns Sep 13, 2017 ▶ 32:33 Elizabeth Iorns on Biotech Companies in YC · Y Combinator
TOP FOUNDERS Assertion Supported
Campbell: There is over 80% waste in clinical trial funding
“Most clinical trials don't result in there, there's an excess of 80% waste in, in funding of clinical trials today, and yet this is life-saving research.”
Lane Campbell Apr 2, 2016 ▶ 3:32 Sold 5 Companies Before Age of 30, Now Side Stream Income is $500k/Year with Lane Campbell EP 218
MAD Disclosure
Flatiron targets data from the 95% of cancer patients outside trials
“So we don't touch that piece of the market. That's about four to five percent of patients will go on a trial. We look at the 95% who are not on a trial.”
Zach Weinberg Feb 18, 2015 ▶ 25:42 Zach Weinberg, Flatiron Health // Using Data to Cure Cancer // Data Driven NYC (FirstMark Capital)

← every entity, every show

Made with StarZero

Turn any episode into a week of clips.

This entire site, thousands of episodes across every show transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.